Abstract

Objective: A systematic review of the literature was conducted relating to the continuation of warfarin therapy at the time of coronary angiography, with or without percutaneous coronary intervention, to determine the bleeding risk of these patients. Methods: A search of a major electronic database was independently conducted by two reviewers from 1960 to December 2009. Studies were included if they met the following criteria: were original; included patients who were undergoing coronary angiography/catheterization with or without angioplasty/stent placement and were receiving uninterrupted warfarin therapy throughout the periprocedural period; and reported the number of bleeding events and procedure related complications. Based on the inclusion and exclusion criteria, a total of eight studies (one randomized, four cohort and three case series) were included for analysis. Results: The pooled odds ratio (95% CI) for procedure-related complications in continued warfarin versus nonanticoagulated patients, in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call